As of June 2026, 1 paid clinical trial is recruiting for Triple-negative breast cancer in Clovis, California. Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Clovis has approximately 22 recruiting research studies across a wide range of therapeutic areas. California hosts a dense network of world-class research institutions, including UC San Diego Health, Stanford Medicine, UCLA Health, UCSF, City of Hope, and Scripps Research. The state's thriving biotech corridor and diverse patient population make it a national hub for both early-phase and late-phase clinical research.
Researchers run research studies in Clovis, CA at 12 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Community Cancer Institute | Stage IVB Prostate Cancer AJCC v8, B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | 9 |
| University Oncology Associates | Stage IVB Prostate Cancer AJCC v8, B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | 4 |
| Clovis Community Medical Center | Multiple Myeloma | 2 |
| UCSF Fresno | Multiple Myeloma | 2 |
| Women's Specialty & Fertility Center | In Vitro Maturation of Oocytes, Infertility (IVF Patients), Infertility Assisted Reproductive Technology | 2 |
| Community Cancer Institute (CCI) | B-Cell Non-Hodgkins Lymphoma | 1 |
| Community Health Partners (CHP) - Community Medical Oncology Specialists (University Oncology Associates) | Immune Thrombocytopenia | 1 |
| UCSF FRESNO/Community Cancer Institute | Chronic Lymphocytic Leukemia | 1 |
| UCSF-Fresno | Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia | 1 |
| University of California San Francisco - Fresno Center for Medical Education and Research | B-Cell Non-Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma, Relapsed B-Cell Non-Hodgkin Lymphoma | 1 |
| University of California, Fresno | Acute Myeloid Leukemia (AML) | 1 |
| University of California, San Francisco Fresno | Peripheral T Cell Lymphoma | 1 |
Recruiting trials in Clovis grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in California are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. In addition, California-specific protections such as the California Consumer Privacy Act (CCPA) and the Confidentiality of Medical Information Act (CMIA) impose stringent data-privacy requirements on research involving California residents.
Hipa.ai aggregates every recruiting study in Clovis from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 22 recruiting clinical trials in Clovis, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Clovis compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Clovis include Multiple Myeloma (4), Stage IVB Prostate Cancer AJCC v8 (2), Acute Myeloid Leukemia (1), Acute Myeloid Leukemia (AML) (1), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Clovis on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Clovis include Community Cancer Institute, University Oncology Associates, Clovis Community Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Clovis are Cancer & tumors (17). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.